CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $960 | +90.5% | 64,404 | +39.9% | 0.00% | 0.0% |
Q2 2023 | $504 | -74.8% | 46,023 | +7780.7% | 0.00% | – |
Q2 2022 | $2,000 | -97.8% | 584 | -98.0% | 0.00% | – |
Q1 2022 | $92,000 | -8.0% | 29,580 | 0.0% | 0.00% | – |
Q4 2021 | $100,000 | -7.4% | 29,580 | -0.4% | 0.00% | – |
Q3 2021 | $108,000 | -55.0% | 29,701 | -46.0% | 0.00% | – |
Q2 2021 | $240,000 | -2.8% | 54,965 | +1.0% | 0.00% | – |
Q1 2021 | $247,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
Q4 2020 | $312,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
Q3 2020 | $394,000 | +107.4% | 54,400 | 0.0% | 0.00% | – |
Q2 2020 | $190,000 | +134.6% | 54,400 | 0.0% | 0.00% | – |
Q1 2020 | $81,000 | -24.3% | 54,400 | 0.0% | 0.00% | – |
Q4 2019 | $107,000 | -61.6% | 54,400 | 0.0% | 0.00% | – |
Q3 2019 | $279,000 | -44.8% | 54,400 | -22.8% | 0.00% | -100.0% |
Q2 2019 | $505,000 | -30.0% | 70,500 | +29.8% | 0.00% | 0.0% |
Q1 2019 | $721,000 | +68.9% | 54,300 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $427,000 | -41.2% | 54,300 | -17.1% | 0.00% | 0.0% |
Q3 2018 | $726,000 | -17.4% | 65,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $879,000 | – | 65,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |